T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBIO
1151
DELISTED
Generation Bio
GBIO
| $9.84M | ﹤0.01% |
927,906
-7,253
| -0.8% | -$129K |
|
1152
Applied Optoelectronics
AAOI
$11B
| $9.83M | ﹤0.01% |
266,606
+150,770
| +130% | +$4.06M |
|
1153
Intapp
INTA
$3.05B
| $9.81M | ﹤0.01% |
152,992
+133,108
| +669% | +$7.63M |
|
1154
Avantor
AVTR
$9.37B
| $9.76M | ﹤0.01% |
463,311
-73,420
| -14% | -$1.65M |
|
|
WBA
1155
DELISTED
Walgreens Boots Alliance
WBA
| $9.71M | ﹤0.01% |
1,040,785
+21,533
| +2% | +$200K |
|
1156
Doximity
DOCS
$4.74B
| $9.65M | ﹤0.01% |
180,743
-127,483
| -41% | -$6.24M |
|
1157
WisdomTree
WT
$3.44B
| $9.63M | ﹤0.01% |
916,657
+265,687
| +41% | +$2.88M |
|
1158
Acuity Brands
AYI
$10.8B
| $9.6M | ﹤0.01% |
32,841
+5,402
| +20% | +$1.69M |
|
1159
Lumentum
LITE
$78B
| $9.6M | ﹤0.01% |
114,288
+56,464
| +98% | +$4.4M |
|
1160
Bio-Rad Laboratories Class A
BIO
$9.68B
| $9.57M | ﹤0.01% |
29,144
+1,524
| +6% | +$517K |
|
1161
Dutch Bros
BROS
$8.93B
| $9.56M | ﹤0.01% |
182,444
+130,931
| +254% | +$5.78M |
|
1162
Allogene Therapeutics
ALLO
$683M
| $9.55M | ﹤0.01% |
4,485,572
-353,171
| -7% | -$871K |
|
1163
Plexus
PLXS
$7.25B
| $9.49M | ﹤0.01% |
60,639
+1,515
| +3% | +$232K |
|
1164
Fortune Brands Innovations
FBIN
$5.83B
| $9.43M | ﹤0.01% |
137,917
+22,443
| +19% | +$1.8M |
|
1165
Graco
GGG
$13.3B
| $9.23M | ﹤0.01% |
109,459
+4,948
| +5% | +$429K |
|
1166
TD Synnex
SNX
$20.4B
| $9.04M | ﹤0.01% |
77,055
-79,656
| -51% | -$9.54M |
|
1167
Jefferies Financial Group
JEF
$12.9B
| $8.98M | ﹤0.01% |
114,592
+6,098
| +6% | +$439K |
|
|
PARA
1168
DELISTED
Paramount Global Class B
PARA
| $8.96M | ﹤0.01% |
856,921
+3,869
| +0.5% | +$41.6K |
|
1169
TG Therapeutics
TGTX
$7.34B
| $8.94M | ﹤0.01% |
297,101
+215,601
| +265% | +$6.19M |
|
1170
Mohawk Industries
MHK
$9.27B
| $8.86M | ﹤0.01% |
74,333
-168
| -0.2% | -$23.5K |
|
1171
Franklin Resources
BEN
$17.1B
| $8.78M | ﹤0.01% |
432,620
+2,757
| +0.6% | +$58.1K |
|
1172
Unum
UNM
$14.7B
| $8.67M | ﹤0.01% |
118,709
+11,589
| +11% | +$799K |
|
1173
Okta
OKTA
$26.9B
| $8.63M | ﹤0.01% |
109,561
-4,876
| -4% | -$378K |
|
1174
Pharvaris
PHVS
$2.55B
| $8.51M | ﹤0.01% |
443,896
+118,408
| +36% | +$2.44M |
|
1175
Fox Class B
FOX
$24.4B
| $8.42M | ﹤0.01% |
184,000
+2,347
| +1% | +$98.8K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.